B7-H4 Recombinant Rabbit mAb (SDT-314-447-2)

產(chǎn)品型號(hào)：S0B2235

更新時(shí)間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問量：77

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

癌癥治療新紀(jì)元：ADC藥物如何以“精準(zhǔn)制導(dǎo)+超級(jí)彈頭“改寫抗癌規(guī)則？

成纖維細(xì)胞生長(zhǎng)因子21：代謝調(diào)控的新星與治療前沿

GFAP Mouse mAb的應(yīng)用領(lǐng)域有哪些？

產(chǎn)品介紹

B7-H4 is a transmembrane protein that binds an unknown receptor on activated T cells resulting in inhibition of T-cell effector function via cell cycle arrest, decreased proliferation, and reduced IL-2 production. B7-H4 is up-regulated on the surface of cancer cells and immunosuppressive tumor-associated macrophages （TAMs） in a variety of human cancers. Notably, B7-H4 expression levels inversely correlate with patient survival in ovarian cancer, cholangiocarcinoma, breast cancer and endometrial cancer, making B7-H4 an attractive candidate for therapeutic intervention.

上一個(gè)：S0B2234B7-H4 Recombinant Rabbit mAb (SDT-314-447)